New approaches to treatment of dementia: Optimizing resident function and caregiver efficiency

Journal of the American Medical Directors Association

Volumn 3, Issue 4 SUPPL., 2002, Pages

  Tangalos, Eric C ^a   Agronin, Marc ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLOZAPINE; DONEPEZIL; GALANTAMINE; HALOPERIDOL; MEMANTINE; NERVE GROWTH FACTOR; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; TACRINE; THIORIDAZINE; ZIPRASIDONE;

AGED; AGITATION; ALGORITHM; ALZHEIMER DISEASE; BRADYCARDIA; BRONCHUS SECRETION; CARDIOVASCULAR DISEASE; CAREGIVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DRUG MECHANISM; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; LIVER DYSFUNCTION; NAUSEA AND VOMITING; NOTE; PSYCHOSIS; STOMACH SECRETION; TARDIVE DYSKINESIA; WEIGHT GAIN;

EID: 0036060169     PISSN: 15258610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-8610(04)70509-5     Document Type: Article

References (6)

1. FJ Molnar WB Dalziel The pharmacoeconomics of dementia therapies: Bring the clinical, research and economic perspectives together Drugs Aging 10 1997 219 233
2. MA Raskind ER Peskind T Wessel Galanthamine in AD. A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galanthamine USA-1 Study Group Neurology 54 2000 2261 2268
3. SL Rogers LT Friedhoff The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group Dementia 7 1996 293 303
4. PN Tariot Treatment of agitation in dementia J Clin Psychiatry 60 suppl 8 1999 11 20
5. LE Tune Anticholinergic effects medication in elderly patients J Clin Psychiatry 62 suppl 21 1982 11 11
6. B Winblad A Wimo HJ Moblus L Fratiglioni Severe dementia: a common condition entailing high costs at individual and societal levels Int J Geriat Psychiatry 14 1999 911 914